Skip To Main Content
Sonia Berrih-Aknin on Muck Rack

Sonia Berrih-Aknin

As seen in: BMJ Open, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sonia

Contact Sonia, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Patient-reported impact of myasthenia gravis in the real world: findings from a digital observational survey-based study (MyRealWorld MG)

|
By Sonia Berrih-Aknin, Andreas Meisel, Kristl G. Claeys, Srikanth Muppidi
| BMJ Open Verified
Discussion This analysis of baseline data from 1693 adults living with MG across seven countries revealed a moderate participant-reported burden, despite effective treatment being actively received. Reporting participants were likely to experience at least one of a wide range of comorbidities, alongside symptoms attributed to side effects such as tiredness and muscle twitches.
Open in Who Shared View Duplicates (2) Issue with article?

New Approaches to Targeting B Cells for Myasthenia Gravis Therapy

|
By Pilar Martinez, Sonia Berrih-Aknin, Guenter Steiner
| Frontiers
Introduction Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder. Patients with MG who are seropositive for autoantibodies to the acetylcholine receptor (AChR), muscle-specific tyrosine kinase (MuSK), or low-density lipoprotein receptor-related protein 4 (LRP4) present with voluntary muscle weakness due to dysfunctional neuromuscular junctions and impaired neuromuscular transmission (1, 2).
Open in Who Shared Issue with article?
See all 2 articles